<VariationArchive RecordType="classified" VariationID="39416" VariationName="NM_004614.5(TK2):c.8dup (p.Trp4fs)" VariationType="Duplication" Accession="VCV000039416" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-12-17" DateCreated="2016-08-22" MostRecentSubmission="2016-08-22">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="48015" VariationID="39416">
      <GeneList>
        <Gene Symbol="TK2" FullName="thymidine kinase 2" GeneID="7084" HGNC_ID="HGNC:11831" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="66508003" stop="66550291" display_start="66508003" display_stop="66550291" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="66541905" stop="66584314" display_start="66541905" display_stop="66584314" Strand="-" />
          </Location>
          <OMIM>188250</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004614.5(TK2):c.8dup (p.Trp4fs)</Name>
      <CanonicalSPDI>NC_000016.10:66550053:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>16q21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="66550053" stop="66550054" display_start="66550053" display_stop="66550054" variantLength="1" positionVCF="66550053" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="66583956" stop="66583957" display_start="66583956" display_stop="66583957" variantLength="1" positionVCF="66583956" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.66550054dup" Assembly="GRCh38">
            <Expression>NC_000016.10:g.66550054dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.66583957dup" Assembly="GRCh37">
            <Expression>NC_000016.9:g.66583957dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016862.1" sequenceAccession="NG_016862" sequenceVersion="1" change="g.5359dup">
            <Expression>NG_016862.1:g.5359dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_017618.1" sequenceAccession="NM_017618" sequenceVersion="1" change="c.373dup">
            <Expression>NM_017618.1:c.373dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_060088.1" sequenceAccession="NP_060088" sequenceVersion="1" change="p.Ser125Lysfs">
            <Expression>NP_060088.1:p.Ser125Lysfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001172644.2" sequenceAccession="NM_001172644" sequenceVersion="2" change="c.8dup">
            <Expression>NM_001172644.2:c.8dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001166115.1" sequenceAccession="NP_001166115" sequenceVersion="1" change="p.Trp4fs">
            <Expression>NP_001166115.1:p.Trp4fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001172645.2" sequenceAccession="NM_001172645" sequenceVersion="2" change="c.8dup">
            <Expression>NM_001172645.2:c.8dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001166116.1" sequenceAccession="NP_001166116" sequenceVersion="1" change="p.Trp4fs">
            <Expression>NP_001166116.1:p.Trp4fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271934.2" sequenceAccession="NM_001271934" sequenceVersion="2" change="c.-235dup">
            <Expression>NM_001271934.2:c.-235dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001272050.2" sequenceAccession="NM_001272050" sequenceVersion="2" change="c.-645dup">
            <Expression>NM_001272050.2:c.-645dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004614.5" sequenceAccession="NM_004614" sequenceVersion="5" change="c.8dup" MANESelect="true">
            <Expression>NM_004614.5:c.8dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004605.4" sequenceAccession="NP_004605" sequenceVersion="4" change="p.Trp4fs">
            <Expression>NP_004605.4:p.Trp4fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_073520.2" sequenceAccession="NR_073520" sequenceVersion="2" change="n.69dup">
            <Expression>NR_073520.2:n.69dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271935.1" sequenceAccession="NM_001271935" sequenceVersion="1" change="c.31+199dup">
            <Expression>NM_001271935.1:c.31+199dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001172643.1" sequenceAccession="NM_001172643" sequenceVersion="1" change="c.31+199dup">
            <Expression>NM_001172643.1:c.31+199dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="188250.0005" DB="OMIM" />
        <XRef Type="rs" ID="281865502" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004614.5(TK2):c.8dup (p.Trp4fs) AND Mitochondrial DNA depletion syndrome, myopathic form" Accession="RCV000032592" Version="26">
        <ClassifiedConditionList TraitSetID="3454">
          <ClassifiedCondition DB="MedGen" ID="C3149750">Mitochondrial DNA depletion syndrome, myopathic form</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-02-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2012-02-28" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-08-22" MostRecentSubmission="2016-08-22">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22345218</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3454" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2956" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Mitochondrial DNA depletion syndrome 2</ElementValue>
                <XRef ID="Mitochondrial+DNA+depletion+syndrome+2/8897" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mitochondrial DNA depletion syndrome, myopathic form</ElementValue>
                <XRef ID="MONDO:0012301" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">TK2-Related Mitochondrial DNA Depletion Syndrome, Myopathic Form</ElementValue>
                <XRef ID="NBK114628" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)</ElementValue>
                <XRef Type="MIM" ID="609560" DB="OMIM" />
                <XRef Type="Allelic variant" ID="188250.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="188250.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="188250.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="188250.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="188250.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="188250.0001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MITOCHONDRIAL DNA DEPLETION MYOPATHY, TK2-RELATED</ElementValue>
                <XRef Type="MIM" ID="609560" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MTDPS2</ElementValue>
                <XRef Type="MIM" ID="609560" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">TK2-Related Mitochondrial DNA Maintenance Defect, Myopathic Form</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">TK2-related mitochondrial DNA (mtDNA) maintenance defect is a phenotypic continuum that ranges from severe to mild. To date, approximately 107 individuals with a molecularly confirmed diagnosis have been reported. Three main subtypes of presentation have been described: Infantile-onset myopathy with neurologic involvement and rapid progression to early death. Affected individuals experience progressive muscle weakness leading to respiratory failure. Some individuals develop dysarthria, dysphagia, and/or hearing loss. Cognitive function is typically spared. Juvenile/childhood onset with generalized proximal weakness and survival to at least 13 years. Late-/adult-onset myopathy with facial and limb weakness and mtDNA deletions. Some affected individuals develop respiratory insufficiency, chronic progressive external ophthalmoplegia, dysphagia, and dysarthria.</Attribute>
                <XRef ID="NBK114628" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23230576</ID>
                <ID Source="BookShelf">NBK114628</ID>
              </Citation>
              <XRef ID="254875" DB="Orphanet" />
              <XRef ID="C3149750" DB="MedGen" />
              <XRef ID="MONDO:0012301" DB="MONDO" />
              <XRef Type="MIM" ID="609560" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="93536" SubmissionDate="2016-08-12" DateLastUpdated="2016-08-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="188250.0005_MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)" title="TK2, 8-BP DUP_MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)" />
        <ClinVarAccession Accession="SCV000056343" DateUpdated="2016-08-22" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-02-28">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an adult man with slowly progressive mitochondrial DNA depletion syndrome-2 (MTDPS2; 609560), Behin et al. (2012) identified compound heterozygosity for 2 mutations in the TK2 gene: an 8-bp duplication in exon 1, resulting in a frameshift and premature termination (Trp4ValfsTer40), and a 268C-T transition in exon 4, resulting in an arg90-to-cys (R90C; 188250.0006) substitution in a region important for TK2 dimer stabilization. Each unaffected parent was heterozygous for 1 of the mutations. TK2 activity in patient fibroblasts was 4% of controls. The patient had mild ptosis at age 13 years, dysarthria at age 15, and proximal lower limb weakness at age 25. At age 31, he presented with ptosis, upper gaze limitation, hypophonia, axial and limb muscle weakness, and respiratory insufficiency, although he remained ambulatory. Laboratory investigations showed mild increased serum creatine kinase, and skeletal muscle biopsy showed mitochondrial defects with mtDNA depletion (about 30% residual mtDNA compared to controls).</Attribute>
              <Citation>
                <ID Source="PubMed">22345218</ID>
              </Citation>
              <XRef DB="OMIM" ID="609560" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TK2" />
          </GeneList>
          <Name>TK2, 8-BP DUP</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">8-BP DUP</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="188250.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="93536" TraitType="Disease" MappingType="Name" MappingValue="MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)" MappingRef="Preferred">
        <MedGen CUI="C3149750" Name="Mitochondrial DNA depletion syndrome, myopathic form" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

